Yerxa Benjamin R's Form 4 filing
Opus Genetics, Inc. (IRD) · filed Nov 25, 2024
- Accession no.
- 0000905148-24-003268
- Filed
- Nov 25, 2024
- Trade date
- Nov 21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $9.80K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yerxa Benjamin RCIK 0001145910 | Director, Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Common Stock | PPurchaseAcquired | +10,000 | $0.98 | +$9,800 | 342,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.